Stablepharma is a pioneering brand in the field of vaccine development and distribution. Our founder, Dr. Bruce Roser, has dedicated decades to groundbreaking research that led to the discovery of a revolutionary technology.

This innovative approach eliminates the need for the global cold chain, making it possible to produce and distribute fridge-free vaccines for the treatment and prevention of serious diseases. Did you know that up to 50% of global vaccines are wasted due to failures in the cold chain? That's according to the World Health Organization. However, thanks to Stablepharma's StablevaX™ technology, fridge-free vaccines are now a reality.

By reformulating existing vaccines, our unique approach enables safe and efficient distribution and storage, even in the most inhospitable parts of the world. Our mission goes beyond improving vaccine stability and reducing wastage. We also aim to make a significant impact on global health outcomes, as well as the environment.

The storage and transportation of vaccines have a considerable carbon footprint. By eliminating the need for the cold chain, Stablepharma is actively working to reduce CO2 emissions and minimize our ecological impact. Join us in this important journey towards a more sustainable and effective vaccine distribution system.

Contact us today to learn more about Stablepharma and our game-changing StablevaX™ technology